Review details MRI features and protocol for MOGAD diagnosis
This review summarizes characteristic MRI findings in MOGAD affecting the optic nerve, brain, and spinal cord, as incorporated into the 2023 diagnostic criteria. The authors describe radiologic lag, acute lesion dynamics, and frequent T2-lesion resolution as distinguishing MOGAD from the persistent lesions typical of MS, and report that asymptomatic radiological activity is rare, suggesting surveillance MRI has less clinical utility than in MS. The review proposes a standardized MRI protocol for acute attacks and rebaselining, and outlines imaging red flags for alternative diagnoses.
Most relevant for: Clinicians evaluating patients with suspected demyelinating disease, particularly those distinguishing MOGAD from multiple sclerosis or AQP4-positive neuromyelitis optica spectrum disorder.
Read the original at JAMA NeurologySummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More neurology updates
- Intensive BP Lowering Benefits Deep but Not Lobar HemorrhageNov 10, 2026
- Earlier Blood Biomarker Disclosure Boosts Diagnostic Certainty in Memory ClinicOct 5, 2026
- Iatrogenic cerebral amyloid angiopathy linked to high recurrent hemorrhage riskOct 27, 2026
- Study identifies clinical risk factors for chemotherapy-induced nerve toxicityOct 27, 2026
- Cervical cord atrophy in MS exceeds normal age-related declineOct 27, 2026